Inventprise
PrivateLast Round
Series A
May 4, 2023
Total Funding Raised
$115.83M
Company Overview
Inventprise operates in Healthcare & Life Sciences and is based in Redmond, Washington. Its latest recorded funding round was a Series A round in May 2023.
Inventprise is a biotechnology company that develops high-valency vaccines for infectious diseases using proprietary linker conjugation technology and automated manufacturing processes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inventprise Comparables
Compare Inventprise with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GSK plc | 80% | |
| GPN Vaccines | 79% | |
| Vaxcyte | 79% |
For institutional investors. Book with your work email.
Inventprise Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 4, 2023 | ||||
| Grant | Apr 7, 2022 | ||||
| VC Round | Nov 10, 2021 | ||||
| Grant | Mar 1, 2021 | ||||
| Debt | Jun 3, 2020 | ||||
Grant | Mar 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Inventprise Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gates Foundation | Grant |
| The Bill & Melinda Gates Foundation Trust | Grant, Series A, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2025
76 employees impacted according to state filing.
- May 15, 2025
Developing an RSV vaccine as a proof of concept.
For institutional investors. Book with your work email.
Inventprise Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Inventprise's valuation, stock price, and market status.
Is Inventprise a public or private company?
Inventprise is a private company.
What is the current stock price of Inventprise?
Inventprise is a private company, so its shares have no public market price. Caplight tracks Inventprise's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Inventprise worth (valuation)?
Valuation information for Inventprise is not publicly available.
Can I buy Inventprise stock?
Inventprise shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Inventprise's last funding round?
Inventprise's most recent funding round was Series A on May 4, 2023.
Who are the main investors in Inventprise?
Key investors in Inventprise include The Bill & Melinda Gates Foundation Trust.
Will Inventprise IPO soon?
No public IPO plans have been announced for Inventprise.
How can I track Inventprise secondary market activity?
Caplight tracks bids, offers, and trades in Inventprise's shares on secondary markets.